We hypothesize that p53 mutations mediate tumor escape from T-cells in PDAC, and test whether subsets of p53 mutations in PDAC tumors impact T-cell migration and killing, using novel in vitro and inducible in vivo models, to characterize a new role for p53’s regulation in cancer. The gene discussed is TP53; the disease is cancer.